News From Elixir Pharmaceuticals14 years, 4 months ago
Posted on Nov 17, 2004, 3 a.m.
By Bill Freeman
A press release notes a new license and research direction. "Elixir Pharmaceuticals, Inc. announced today that it has licensed intellectual property [relating to] NaCT-1, a human ortholog of the longevity gene, INDY . Our research suggests that aging is a carefully regulated metabolic process. The INDY gene product is an excellent example of an anti-aging target that has been proven to play a role in the cellular regulation of lipid and carbohydrate metabolism.
View the Article Under Discussion: http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20041116005245&newsLang=en
Read More Longevity Meme Commentary: http://www.longevitymeme.org/news/